Hypertension in Saskatchewan

A new study published in the Canadian Pharmacists Journal, shows that comprehensive long-term pharmacist care for Canadians with hyertension, including patient education and prescribing, improves health outcomes and will save money for Saskatchewan and Canada's health care system. For Saskatchewan, there is a potential savings of $423 million dollars. Pharmacists are in a unique position to help contribute to patient-centred care.

The peer-reviewed study looked at alternatives to usual hypertension care, including full scope pharmacist care—making full use of pharmacists’ scope of skills, including prescribing. The analysis shows a real and significant benefit from pharmacist care both in terms of cost savings and health benefits when compared to usual care.

For the full provincial report, see below

Saskatchewan Hypertension Study 

The model presented in the report has an interactive tool which allows users to explore changes in economic and health impacts in different time frames and health scenarios.  

https://models.broadstreetheor.com/CPhA/CEA/index.html#

Simplified version of the app:

https://models.broadstreetheor.com/CPhA/Scenarios/index.html

 

The national report is available below. 

National Hypertension Study

National Study Q & A 

Hypertension Video

Please visit the Canadian Pharmacists Association website for further information on the national report. 

What's New

Influenza Immunization Program Reminders

An email was sent out to PAS members on October 31, 2018, reminding them about off-site immunizations and the influenza immunizations fees.

More

New One-year Agreement

The provincial government and the Pharmacy Association of Saskatchewan (PAS) have reached a new one-year agreement.

More

2018-2019 Influenza Immunization Program

PAS has created a host of support documents once again as pharmacists prepare for the upcoming 2018-2019 Saskatchewan Influenza Immunization Program that will begin Oct 22, 2108, including information for injecting patients age 5-8 and patients living in

More

Update on the EpiPen® Shortage

There is a recent update from Pfizer Canada on EpiPen® and EpiPen Jr® auto-injectors.

More
View All